Givaudan | GIVN - Current Assets


Givaudan reported CHF4.07B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Air Liquide EUR 9.96B 33.3M Jun/2026
Akzo Nobel EUR 8.12B 594M Jun/2026
Anheuser-Busch USD 22.24B 2.53B Jun/2026
Arkema EUR 4.8B 37.7M Jun/2026
Associated British Foods GBP 6.2B 225M Dec/2025
BASF EUR 38.79B 1.18B Jun/2026
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
British American Tobacco GBP 11.92B 761M Jun/2026
Covestro EUR 5.91B 259M Dec/2025
Croda International GBP 884.2M 36.4M Dec/2024
Danone EUR 16.06B 2.83B Jun/2026
Diageo GBP 18.89B 1.4B Dec/2025
Fresenius EUR 12.07B 1.04B Mar/2026
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Givaudan CHF 4.07B 258M Dec/2025
Heineken EUR 12.89B 1.81B Dec/2025
Henkel EUR 10.07B 268M Dec/2025
International Flavors Fragrances USD 9.09B 3.65B Jun/2026
Johnson Matthey GBP 3.94B 105M Jun/2026
Kerry EUR 3.05B 282.4M Jun/2026
Lonza CHF 8B 3.41B Dec/2025
L'Oréal EUR 17.97B 4.23B Jun/2026
Merck EUR 14.16B 932M Mar/2026
Nestle CHF 37.58B 5.61B Jun/2026
Pernod Ricard EUR 13.04B 751M Dec/2025
Reckitt Benckiser GBP 4.6B 287M Dec/2024
SGS CHF 2.85B 186M Dec/2024
Sika AG CHF 4.41B 242.1M Dec/2025
Solvay EUR 2.05B 143M Jun/2026
Tate & Lyle GBP 1.33B 73M Jun/2026
Umicore EUR 6.36B 621M Jun/2026
Victrex GBP 189.3M 3.9M Jun/2026